PharmaTrail´s pilot with The McGuire Institute successfully completed!

08 September 2023
We are thrilled to share that PharmaTrail has successfully completed the pilot study with the The McGuire Institute!
We extend our heartfelt thanks to the incredible staff and participants. Your invaluable insights and feedback have been instrumental in refining our software solutions to meet the highest standards of usability, effectiveness, and security.
This achievement brings us one step closer toward our mission of improving healthcare outcomes and experiences. Stay tuned for more updates as we are preparing the 1.0 release of PharmaTrail's Clinical Trial Software.

PharmaTrail´s eCOA Module in pilot phase!

12 July 2023

We are excited to announce the initiation of the pilot phase for our electronic Clinical Outcome Assessment (eCOA) module together with the esteemed McGuire Institute!

This milestone represents a significant leap forward in the development of our cutting-edge solution.

PharmaTrail is strengthening the team!

03 July 2023

We are thrilled to announce that we are strengthening our team with product management industry experts.

These new hires will play a pivotal role in driving innovation, bringing invaluable know-how, expertise, and fresh perspectives to further propel PharmaTrail´s growth.

Successful first closing of Series A2 financing round

07 March 2023

We are excited to announce the successful first closing of our A2 financing round!

This will allow us to accelerate our developments towards a full product suite that will help to better serve patients, sites, sponsors and regulatory agencies.

We are grateful to have the support of a strong group of investors who share PharmaTrail’s vision and the potential of blockchain as the new standard for ensuring data security, integrity, and transparancy in clinical trials.

Successful closure of eConsent pilot study!

06 March 2023

Our eConsent pilot study has concluded successfully! We would like to express our sincere gratitude to the clinical trial sites and participants for the time and dedication in testing as well as our partner BioValeo for all their support. Their valuable feedback will be instrumental in helping us improve our software and provide the best user experience possible!

Successful start of eConsent pilot study!

06 February 2023

We are thrilled to announce that our eConsent pilot study has been started successfully together with our partner BioValeo. Our blockchain-based platform is now working under real-life conditions!

Growing the PharmaTrail Team

01 January 2023

We are happy to announce that our team is growing with two highly talented new members.

Damian Schraube joined the PharmaTrail team as Head of Product Management. Damian brings with him >15 years of experience in clinical trials and clinical trial IT systems both within CROs and Pharma companies. With his unique expertise we are convinced that Damian will help PharmaTrail to develop software that will be real assets to our customers. We are excited to have Damian on the PharmaTrail team.

Jonas Placzek has joined the PharmaTrail team as Junior Product Manager. Jonas did his Bachelor in medical computer science and his thesis with PharmaTrail last year. As a passionist about UI/UX we are looking forward to his contribution to PharmaTrail’s Clinical Trial Suite and are convinced that he will enable PharmaTrail to provide superior solutions to our customers.

PharmaTrail joins PharmaLedger Association

01 January 2023
PharmaTrail has joined the PharmaLedger Association (PLA) as a Member. PLA – which came out of the PharmaLedger IMI and Horizon 2020 project – is dedicated to bringing the benefits of blockchain to the Pharma-environment and to create a Digital Trust Ecosystem in healthcare. This is in line with our vision to use blockchain for building trust and transparency in clinical trials. We are looking forward to working with the PharmaLedger Association to shape the future of blockchain use cases in pharma together.

PharmaTrail as contributor to EFGCP´s eConsent Initiative

20 September 2022
PharmaTrail has joined the European Forum for GCP’s Informed Consent Initiative. Our Head of Business Development Rebecca Zeising is actively contributing to the EFGCP’s Informed Consent initiative, which will pave the way for a harmonized European eConsent understanding and environment. We are excited to be part of this essential initiative!

PharmaTrail AG
Schneidergasse 7
CH-4051 Basel
This email address is being protected from spambots. You need JavaScript enabled to view it.

Member of